Recall Register

Food, drugs, devices › Mindray DS USA, Inc. dba Mindray North America

Device recall: TD60 display Telemetry Transmitter, SHENZHEN Mindray Bio-Medical Electronics Co., LTD, Mindray Building, Keji 12th Road

FDA enforcement event 75062 · Class II · initiated 8 Sep 2016 · status Terminated · terminated 4 May 2017

DeviceVoluntary: Firm initiated1 product recordMahwah, NJ

FDA enforcement event 75062 is a device recall by Mindray DS USA, Inc. dba Mindray North America of Mahwah, NJ, initiated 8 Sep 2016 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,232 device enforcement events initiated in 2016 carry the same class.

Status: Terminated, terminated 4 May 2017. Initiation: voluntary: firm initiated. Mindray DS USA, Inc. dba Mindray North America has 29 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Mindray DS USA, Inc. dba Mindray North America, Mahwah, NJ.

Reason for recall

"Mindray has become aware that the TD60 Display Telemetry Transmitter used with the BeneVision Central Station may crack on the bezel surrounding the display and also the transmitter may not power on or will power on but display an error message."

Distribution

"US and Canada"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0321-2017TD60 display Telemetry Transmitter, SHENZHEN Mindray Bio-Medical Electronics Co., LTD, Mindray Building, Keji 12th Road South, Hi-Tech Industrial Partk, Nanshan, Shenzhen, 518057 P.R. China1,278 unitsClass IITerminated9 Nov 2016

Context

91%of 2016 device events are Class II1,232 events that year
1product record in this eventfirm median: 1
29events on this register for the firm

Other enforcement events for Mindray DS USA, Inc. dba Mindray North America

InitiatedProduct (first record)TypeClassRecords
18 Nov 2025Hardware configuration of the BeneVision Central Monitoring System (CMS), marketed as BeneVision Distributed Monitoring DeviceClass II1
20 Oct 2025Sevoflurane (SEVO) V90 Electronic Vaporizer with the A9 Anesthesia System. Labeled as the following: 1. Sev E_Vap. (SafeDeviceClass II2
15 Aug 2025BeneVision N1 Patient Monitor (N1). Part Numbers: 6660E-PA00017, 6660E-PA00014, 6660E-PA00012, 6660E-PA00011, 6660E-PA00DeviceClass II1
22 Jul 2024Sevoflurane E_Vap.(Quik-Fil):used with the A9 Anesthesia System-Used to provide the vapor of an anesthetic agent with coDeviceClass II4
27 May 20213AA battery cradle (Part Number 045-001699-01) used with BeneVision TD60 Telepack (Model Number 115-047566-00 /115-06004DeviceClass III1
22 Feb 2021Mindray BeneVision Distributed Monitoring System( DMS) 1. p/n 115-051209-00 2. p/n 115-034414-00 and 115-034413-00 when DeviceClass II1
13 Jan 2020DP-30 Digital Ultrasonic Diagnostic Imaging System, Part No. 1155E-PA00004 - Product Usage: The Digital Ultrasonic DiagnDeviceClass II1
9 Dec 2019BA-800M Chemistry Analyzer Part Numbers BA81E-PA00002 and BA81E-PA00003, Containing Gas spring YQ-8/18-90-272-180N (MateDeviceClass II2
1 Oct 2019Accutorr 3 Vital Signs Monitor with NIBP valve assembly board, p/n 115-017679-00, containing software version 8.1.5 - PrDeviceClass II4
30 Aug 2018Mindray BeneVision Distributed Monitoring System (DMS), Part No. 115-034413-00DeviceClass II1

All 29 events for Mindray DS USA, Inc. dba Mindray North America

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Mindray has become aware that the TD60 Display Telemetry Transmitter used with the BeneVision Central Station may crack on the bezel surrounding the display and also the transmitter may not power on or will power on but display an error message."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US and Canada"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 4 May 2017. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.